Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This research study is studying radiation therapy in combination with an immunotherapy as a possible treatment for metastatic hormone receptor (HR) positive, HER2-negative breast cancer. The interventions involved in this study are: * Palliative Radiotherapy * Pembrolizumab
Epistemonikos ID: b04e3820178aaf1685ad1eb66d48bfe91941854d
First added on: May 20, 2024